TrkA Immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor

Molecular and Cellular Biology

Volumn 20, Issue 16, 2000, Pages 5908-5916

  Arevalo, J C ^a   Conde, B ^a   Hempstead, B L ^a   Chao, M V ^a   Martin Zanca, D ^a   Perez, P ^a  

^a CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CONFORMATIONAL TRANSITION; DIMERIZATION; HUMAN; HUMAN CELL; LIGAND BINDING; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; RECEPTOR BINDING;

AMINO ACID SUBSTITUTION; ANIMALS; BINDING SITES; LIGANDS; MICE; NERVE GROWTH FACTOR; PROTEIN BINDING; RECEPTOR, TRKA; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; MUS MUSCULUS;

EID: 0033860103     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.16.5908-5916.2000     Document Type: Article

References (37)

1. Neurotrophic factors and their receptors
2. The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction
3. Biology and genetics of human neuroblastomas
4. Transphosphorylation of the neurotrophin Trk receptors
5. Human trk oncogenes activated by point mutation, in-frame deletion, and duplication of the tyrosine kinase domain
6. The role of neurotrophins in the developing of nervous system
7. Antiproliferative effect of the kinase inhibitor K252a on human prostatic carcinoma cell lines
8. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid specific TRK oncogenes
9. Role of the TGF N-terminus and coiled-coil domain in the transforming activity of the thyroid TRK-T3 oncogen
10. PC12 cell mutants that possess low but not high affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor
11. Dimerization of cell surface receptor in signal transduction
12. Expression of functional nerve growth factor receptors after gene transfer
13. Immunoglobulin-like domains define the nerve growth factor binding site of the TrkA receptor
14. Receptor signaling: When dimerization is not enough
15. Nerve growth factor mediates signal transduction through trk homodimer receptors
16. Deletions in the extracellular domain of rat TrkA lead to an altered differentiative phenotype in neurotrophin responsive cells
17. High affinity nerve growth factor binding displays a faster rate of association than p140trk binding
18. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences
19. Molecular and biochemical characterization of the human trk proto-oncogene
20. A common mutation in the fibroblast growth receptor 1 gene in Pfeiffer syndrome
21. Ligand-independent activation of fibroblast growth factor receptors by point mutations in the extracellular, transmembrane and kinase domains
22. Immunoglobulin-like domain 4-mediated receptor-receptor interactions contribute to platelet-derived growth factor-induced receptor dimerization
23. NGF binding to the trk tyrosine kinase receptor requires the extracellular immunoglobulin-like domains
24. Structural basis for FGF receptor dimerization and activation
25. Activating mutations in the extracellular domain of the fibroblast growth factor receptor 2 function by disruption of the disulfide bond in the third immunoglobulin-like domain
26. Molecular cloning: A laboratory manual
27. A novel modular mosaic of cell adhesion motifs in the extracellular domains of the neurogenic trk and trk B tyrosine kinase receptors
28. Sequence profiles of immunoglobuline and immunoglobulin-like domains
29. Signal transduction by receptors with tyrosine kinase activity
30. Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC
31. Oncogenic activation of the αPDGFR defines a domain that negatively regulates receptor dimerization
32. An immunoglobulin-like domain determines the specificity of neurotrophin receptors
33. High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for neurotrophin-3 on the second immunoglobulin-like domain of the Trk receptors
34. Random mutagenesis of CSF-1 receptor (FMS) reveals multiple sites for activating mutations within the extracellular domain
35. Crystal structures of the nerve growth factor in complex with the ligand-binding domain of the TrkA receptor
36. Apert syndrome results from localized mutations of IGFR2 and is allelic with Crouzon syndrome